Hsieh MJ, Lee CH, Chueh HY, Chang GJ, Huang HY, Lin Y, et al
The half-life of injectable BPC-157 is estimated to be a few hours , though exact figures vary depending on the delivery method: Injectable BPC-157: Rapid absorption and clearance, typically 46 hours Oral capsules or sublingual forms: May have extended release times, but reduced bioavailability This means BPC-157 itself doesnt accumulate in your system over timebut the regenerative effects it stimulates (like collagen production and angiogenesis) can continue long after dosing ends
Laboratory studies suggest the peptide interacts with systems involved in nitric oxide signaling, vascular regulation, and cellular movement
Other malabsorption causes include: Atrophic gastritis and reduced gastric acid production (common in older adults) Gastrointestinal surgery, particularly gastrectomy, ileal resection, or bariatric surgery (especially gastric bypass) Inflammatory bowel disease affecting the terminal ileum (Crohn's disease) Coeliac disease and other small bowel disorders Chronic pancreatitis affecting enzyme secretion Helicobacter pylori infection (may contribute to reduced absorption) Medication-related deficiency is increasingly recognised
a healthcare provider may recommend them once a month or even quarterly, depending on individual needs